[144] Ocugen, Inc. SEC Filing

Rhea-AI Filing Summary

Ocugen, Inc. (NASDAQ: OCGN) has filed a Form 144 indicating a planned insider sale. The notice covers the potential disposition of 112,205 common shares—about 0.04 % of the 292.0 million shares outstanding—through Morgan Stanley Smith Barney LLC. The aggregate market value of the planned sale is $122,886.92, implying a reference price near $1.10 per share. The seller acquired the shares on 07/09/2025 via stock-option exercise and intends to sell on or after the same date on the NASDAQ exchange. No other sales were reported in the past three months. By signing the form, the filer asserts there is no undisclosed material adverse information regarding Ocugen.

The filing signals a modest insider liquidity event rather than a strategic transaction; the size is immaterial relative to float and should have limited market impact under normal trading volumes.

Positive

• None.

Negative

• Insider intends to sell shares, which some investors may interpret as a lack of confidence, albeit the amount is immaterial.

Insights

Financial Analyst

TL;DR: Small (0.04%) insider sale signaled; negligible fundamental impact.

The Form 144 covers only 112k shares valued at roughly $123k, a drop in the bucket versus Ocugen’s >292 million share base. Such filings are routine for insiders exercising options and liquidating a portion for tax or diversification. Importantly, the signer affirms no undisclosed negative information. Liquidity events of this scale rarely pressure price unless market sentiment toward the stock is already fragile. I therefore view the disclosure as neutral for valuation and flow dynamics.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	112205	122886.92	292031295	07/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/09/2025	Stock Option Exercise	Issuer			112205	07/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Ocugen (OCGN) shares are being sold under this Form 144?

The notice covers 112,205 common shares.

What percentage of Ocugen’s outstanding shares does the sale represent?

Approximately 0.04 % of the 292,031,295 shares outstanding.

What is the aggregate market value of the proposed sale?

The filing lists an aggregate value of $122,886.92.

When is the earliest proposed sale date for the shares?

The approximate sale date stated is 07/09/2025.

Which broker is handling the transaction?

The shares are to be sold through Morgan Stanley Smith Barney LLC in New York.

Did the filer report any other sales in the past three months?

No. The table of past 3-month sales shows “Nothing to Report.”